SECsense Logo

GRI BIO, INC. 8-K Report: Key Insights for December 20, 2024

$GRI
Form 8-K
Filed on: 2024-12-20
Source
GRI BIO, INC. 8-K Report: Key Insights for December 20, 2024

Based on the provided XML section from a financial report, here are the key points extracted:

  1. Entity Information:
  • Company Name: GRI BIO, INC.
  • CIK Number: 0001824293
  • Incorporation State: Delaware (DE)
  • IRS Employer Identification Number (EIN): 82-4369909
  • Address: 2223 Avenida de la Playa #208, La Jolla, CA 92037
  • Contact Number: 619-400-1170
  1. Filing Type and Date:
  • Filing Type: 8-K (which is typically used for current reports to disclose important events that shareholders should know about)
  • Filing Date: December 20, 2024
  1. Security Information:
  • Type of Security: Common Stock
  • Par Value: $0.0001 per share
  1. Period Information:
  • Reporting Period: The start and end date for this report is December 20, 2024, indicating that this may be a special event or announcement occurring on this specific date.
  1. XML and Namespace Information:
  • The report is structured in XBRL (eXtensible Business Reporting Language) format, which is a standard for exchanging business information.
  • It references specific namespaces and schema, which is important for understanding the data structure and ensuring compliance with SEC requirements.

Insights:

  • The filing is a current report (8-K) dated for a future event, suggesting that GRI BIO, INC. is preparing to disclose significant information or events to its shareholders.
  • The inclusion of the par value for common stock indicates that the company is engaged in equity financing activities, which could be relevant for investors.
  • The precise reporting date indicates a potential upcoming development or event that could impact the company's stock and investor sentiment.

This report could be significant for stakeholders, as timely disclosures are crucial for maintaining transparency and trust in the company’s operations and financial health.